Loading...

Eton Pharmaceuticals ($ETON)

Stock Image

ETON Overview

Eton Pharmaceuticals, a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products.The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension.Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois. (From: StockAnalysis.com)

MORE ABOUT Eton Pharmaceuticals

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.